Regorafenib | High-Quality Pharmaceutical Reference Standard
Regorafenib is a multi-kinase inhibitor used in the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma. It works by inhibiting angiogenic, stromal, and oncogenic kinases, reducing tumor growth. Regorafenib API is produced under GMP standards and is suitable for oral solid dosage formulations, including tablets.
Regorafenib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 4
